Tata Institute claims only Rs 100 tablet can prevent recurrent of cancer
economictimes.indiatimes.com
economictimes.indiatimes.com
I'm quite confused by that. It says human trials will take about five years to complete, but that the tablet is expected to be in the market by June-July.
I would expect that approval for marketing for human use would not be approved until after human trials complete. Is that not the case in India? Or are they talking about some other market, say for use in animals?
It can be sold because it's a flavone and copper supplement meaning both pieces are known separately and are already sold. High dose resveratrol is not exactly inert though - it has drug interactions.
???
Human trials have not been done. That makes this a non story story.
Entertaining article overall.